Lexicon Pharmaceuticals
Pharmaceuticals, 2445 Technology Forest BLVD Ste 1100, The Woodlands, Texas, 77381, United States, 51-200 Employees
Phone Number: 28********
Who is LEXICON PHARMACEUTICALS
Corporate Overview Lexicon Pharmaceuticals is a biopharmaceutical company that has harnessed the power of genetics for drug discovery. Our research team has generated a pipeline of novel ...
Read More
-
Headquarters: 2445 Technology Forest BLVD Ste 1100, The Woodlands, Texas, 77381, United States
-
Date Founded: 1995
-
Employees: 51-200
-
Revenue: $1 Million to $5 Million
-
Active Tech Stack: See technologies
Industry: Pharmaceuticals
SIC Code: 2834
|
NAICS Code: 621111 |
Show More
Does something look wrong? Fix it. | View contact records from LEXICON PHARMACEUTICALS
Lexicon Pharmaceuticals Org Chart and Mapping
Email
Phone
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding Lexicon Pharmaceuticals
Answer: Lexicon Pharmaceuticals's headquarters are located at 2445 Technology Forest BLVD Ste 1100, The Woodlands, Texas, 77381, United States
Answer: Lexicon Pharmaceuticals's phone number is 28********
Answer: Lexicon Pharmaceuticals's official website is https://lexpharma.com
Answer: Lexicon Pharmaceuticals's revenue is $1 Million to $5 Million
Answer: Lexicon Pharmaceuticals's SIC: 2834
Answer: Lexicon Pharmaceuticals's NAICS: 621111
Answer: Lexicon Pharmaceuticals has 51-200 employees
Answer: Lexicon Pharmaceuticals is in Pharmaceuticals
Answer: Lexicon Pharmaceuticals contact info: Phone number: 28******** Website: https://lexpharma.com
Answer: Corporate Overview Lexicon Pharmaceuticals is a biopharmaceutical company that has harnessed the power of genetics for drug discovery. Our research team has generated a pipeline of novel drug candidates in clinical development across a broad range of indications. The Genome: Our Source of Discovery We have applied gene knockout technology to thousands of potential drug targets encoded in the human genome. Our scientists have gained a thorough understanding of target biology and identified new points of intervention for future therapies. We have integrated a series of recombinant DNA and chemistry technologies into a systematic drug discovery and development process. Our unique knowledge of targets from the human genome has allowed us to better evaluate and advance novel drug candidates with great promise for patients. A Diverse Pipeline of Targeted Therapies Our genomics-based approach to drug discovery has enabled our scientists to select drug targets across a broad range of indications with high unmet medical need. All of our drug candidates are new molecular entities discovered internally by our dedicated drug discovery teams and designed to affect particular points on a genetically-defined pathway that can be used to fight a disease process. We have advanced new therapies across a wide spectrum of human disease, from conditions affecting millions of people, such as diabetes, to carcinoid syndrome, an orphan cancer indication with few treatment options.
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month